Niagen Bioscience (NAGE) Cash from Investing Activities Growth (3y) (2016 - 2026)
Niagen Bioscience (NAGE) Cash from Investing Activities Growth (3y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
116.52% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
38.24% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Niagen Bioscience |
277.31 Mn |
210.76 Mn |
19.98 Mn |
290.70% |
| Date | Value |
|---|
| Mar 31, 2026 |
290.70% |
| Dec 31, 2025 |
16.26% |
| Sep 30, 2025 |
22.72% |
| Jun 30, 2025 |
-16.67% |
| Mar 31, 2025 |
-8.58% |
| Dec 31, 2024 |
-225.54% |
| Sep 30, 2024 |
39.75% |
| Jun 30, 2024 |
64.36% |
| Mar 31, 2024 |
3.76% |
| Dec 31, 2023 |
-49.07% |
| Sep 30, 2023 |
23.90% |
| Jun 30, 2023 |
63.40% |
| Mar 31, 2023 |
-65.71% |
| Dec 31, 2022 |
-38.07% |
| Sep 30, 2022 |
30.66% |
| Jun 30, 2022 |
-7.20% |
| Mar 31, 2022 |
56.13% |
| Dec 31, 2021 |
83.16% |
| Sep 30, 2021 |
-5.39% |
| Jun 30, 2021 |
38.02% |
